Status:
COMPLETED
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Reperfusion Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It has been shown that the stress that occurs during cardiac surgery leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to complications aft...
Detailed Description
Patients undergoing cardiac surgery are at significant risk for multiple major complications beyond those associated with other major operations. Most patients survive these events, but up to 10% deve...
Eligibility Criteria
Inclusion
- Adult patients 18 years or older undergoing elective or urgent (prior to hospital discharge) cardiac surgery.
Exclusion
- History of renal insufficiency, nephrolithiasis, G6PD (glucose-6-phosphate dehydrogenase deficiency) or the chronic use of steroids.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01167569
Start Date
October 1 2007
End Date
April 1 2013
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States, 08901